FindTrial
Sign In

Mapping the signet-ring cell in colorectal cancer A spatial epidemiology study in India

Mapping the signet-ring cell colorectal cancer epidemic in India – A spatial epidemiology study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/063324
Enrollment
5000
Registered
2024-02-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: U07-U07- Provisional assignment of new diseases of uncertain etiology or emergency use

Interventions

Intervention1: Not Applicable: Not applicable Control Intervention1: Not Applicable: Not Applicable

Sponsors

Tata memorial hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Histologically confirmed adenocarcinomas of the colon and rectum of all age groups and clinical stages. will be included.

Exclusion criteria

Exclusion criteria: We will exclude non-adenocarcinoma histologies and tumours metastatic to the colon or the rectum. Also excluded will be peritoneal carcinomatosis from an adenocarcinoma of an unknown primary that are sometimes treated as metastatic colorectal cancers.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is the geographic distribution of SRCC in India. The geographic distribution will be recorded and analyzed Timepoint: 2 years—

Secondary

MeasureTime frame
-Compare SRCC & non-SRCC with respect to location of the primary tumour (Colon vs rectum), paying category (General vs private), Age, Sex, religion.Timepoint: 2 years—

Countries

India

Contacts

Public ContactDr Avanish Saklani

Tata memorial hospital

asaklani@hotmail.com7400319886

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026